Atlas Trials

A Phase II Randomised Trial of Three Regimens of GX301 Vaccination in Castration-resistant Prostate Cancer

Clinical trial NCT02293707 · COMPLETED

Trial details

NCT number
NCT02293707
Sponsor
Laboratoires Leurquin Mediolanum
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Prostate Cancer
Start date
2014-11-01
Primary completion
2018-08-01
Enrollment
99

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.